Zobrazeno 1 - 10
of 39
pro vyhledávání: '"D L Barnard"'
Publikováno v:
European Journal of Haematology. 47:81-85
Serial serum erythropoietin levels were measured in 10 consecutive patients undergoing allogeneic bone marrow transplantation. Observed erythropoietin levels are compared with those predicted from a large control population of anaemic patients not re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dae27bec9a901a72c3e4777fd426143
https://doi.org/10.1111/j.1600-0609.1991.tb00126.x
https://doi.org/10.1111/j.1600-0609.1991.tb00126.x
Autor:
R. J. Grace, J. Stone, D. L. Barnard, N. S. A. Stuart, A. V. Simmons, D. Parker, G. J. Dovey, J. Tucker, J. A. Child, M. Morgan, D. R. Norfolk, John Fletcher, L. A. Parapia
Publikováno v:
Hematological Oncology. 9:235-244
Fifty-seven patients, initially diagnosed as having advanced high grade non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) refractory to first-line treatment or in relapse, were treated with ifosfamide 6 g/m2, infused over 48 h, followed by mitox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df1075d15aeb117c9bbf3032ccd72804
https://doi.org/10.1002/hon.2900090409
https://doi.org/10.1002/hon.2900090409
Publikováno v:
The British Journal of Radiology. 76:373-379
Pulmonary complications account for significant morbidity and mortality in patients following bone marrow transplants (BMT). They are distinct from other immunosuppressed patients in that there is a predictable course of immunosuppresion and therefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6264e325dd172e4987170cd52cdac62
https://doi.org/10.1259/bjr/66835905
https://doi.org/10.1259/bjr/66835905
Autor:
D. R. Norfolk, C. Stack, A. V. Simmons, Andrew Jack, C. M. Woodroffe, D. L. Barnard, N. P. Bailey, M. H. Cullen, John Fletcher, Janet A. Dunn, E. Bessell, J. Farish, Robert Grieve, N. S. A. Stuart, J. A. Child
Publikováno v:
Annals of Oncology. 9:633-638
Background: Weekly alternating regimen known as CAPOMEt is compared to standard cyclical chemotherapy (CHOP-Mtx) in aggressive non-Hodgkin's lymphoma (NHL). Patients and methods: Three hundred and eighty-one patients with aggressive NHL were randomis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8950e28f5d63abe19d8b24a1ea85f75
https://doi.org/10.1023/a:1008276700860
https://doi.org/10.1023/a:1008276700860
Autor:
Gareth J. Morgan, Guy Pratt, D. L. Barnard, G. M. Smith, Andy C. Rawstron, Roderick J. Johnson
Publikováno v:
Bone Marrow Transplantation. 21:455-460
Autologous transplantation in CML has been a focus of interest over the last few years. Determining the indications, optimal timing and method for this procedure remains controversial. One approach has been the mobilisation of Philadelphia chromosome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c812f469df37754cd00223a1a4d1c3bc
https://doi.org/10.1038/sj.bmt.1701118
https://doi.org/10.1038/sj.bmt.1701118
Autor:
G. M. Smith, C. M. Woodruffe, D. L. Barnard, M. H. Cullen, John Fletcher, H. Earl, J. A. Child, N. P. Bailey
Publikováno v:
Hematological Oncology. 14:193-201
In a multi-centre phase I study we investigated the possibility of reducing the interval between courses of standard CHOP (cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m2, vincristine 2 mgs day 1, and prednisolone 40 mg/m2 days 1-8) from 21 days to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1597edaa2777f45cfd568b57a7b8082
https://doi.org/10.1002/(sici)1099-1069(199612)14:4<193::aid-hon590>3.0.co
https://doi.org/10.1002/(sici)1099-1069(199612)14:4<193::aid-hon590>3.0.co
Publikováno v:
British Journal of Haematology. 78:23-27
The treatment of chronic graft-versus-host disease (GVHD) may present a difficult therapeutic problem. We used thalidomide to treat six patients with severe chronic GVHD who failed to respond to standard immunosuppressive agents. Four of the six pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::440c2d7c341252a10dcda5953bae2c68
https://doi.org/10.1111/j.1365-2141.1991.tb04377.x
https://doi.org/10.1111/j.1365-2141.1991.tb04377.x
Autor:
L. Parapia, J. Stone, N. S. A. Stuart, D. R. Norfolk, D. L. Barnard, D. Parker, John Fletcher, M. Morgan, J. A. Child, A. V. Simmons, G. J. Dovey, J. Tucker
Publikováno v:
Hematological Oncology. 8:205-213
Fifty-five patients, initially diagnosed as having advanced high grade non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) refractory to first-line treatment or in relapse, were treated with ifosfamide 6 g/m2, infused over 48 h, followed by mitoxa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::966b356dd6b3c6a170c049bc16c91ac0
https://doi.org/10.1002/hon.2900080405
https://doi.org/10.1002/hon.2900080405
Autor:
D L, Barnard
Publikováno v:
IDrugs : the investigational drugs journal. 3(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53b51e066275796ed6cac6402ec421f0
https://pubmed.ncbi.nlm.nih.gov/16080043
https://pubmed.ncbi.nlm.nih.gov/16080043
Autor:
D L, Barnard
Publikováno v:
IDrugs : the investigational drugs journal. 5(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cdf74dfbcf194d834ddefcd9e22c498f
https://pubmed.ncbi.nlm.nih.gov/15570450
https://pubmed.ncbi.nlm.nih.gov/15570450